Annual CFF
$4.50 M
+$9.63 M+187.49%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual cash flow from financing activities is $4.50 million, with the most recent change of +$9.63 million (+187.49%) on December 31, 2023.
- During the last 3 years, HEPA annual CFF has fallen by -$38.56 million (-89.56%).
- HEPA annual CFF is now -94.52% below its all-time high of $81.98 million, reached on December 31, 2021.
Performance
HEPA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.50 M
+$2.50 M+100.00%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly cash flow from financing activities is $2.50 million, with the most recent change of +$2.50 million (+100.00%) on September 30, 2024.
- Over the past year, HEPA quarterly CFF has increased by +$2.50 million (+100.00%).
- HEPA quarterly CFF is now -96.96% below its all-time high of $82.15 million, reached on March 31, 2021.
Performance
HEPA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$8.84 M
+$2.50 M+39.40%
September 30, 2024
Summary
- As of February 7, 2025, HEPA TTM cash flow from financing activities is $8.84 million, with the most recent change of +$2.50 million (+39.40%) on September 30, 2024.
- Over the past year, HEPA TTM CFF has increased by +$11.98 million (+381.90%).
- HEPA TTM CFF is now -92.53% below its all-time high of $118.41 million, reached on March 31, 2021.
Performance
HEPA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
HEPA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +187.5% | +100.0% | +381.9% |
| 3 y3 years | -89.6% | +100.0% | -89.2% |
| 5 y5 years | -64.1% | +100.0% | -89.2% |
HEPA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -94.5% | +187.5% | -44.4% | +179.7% | -89.2% | +272.2% |
| 5 y | 5-year | -94.5% | +187.5% | -97.0% | +179.7% | -92.5% | +272.2% |
| alltime | all time | -94.5% | +187.5% | -97.0% | +179.7% | -92.5% | +272.2% |
Hepion Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.50 M(>+9900.0%) | $8.84 M(+39.4%) |
| Jun 2024 | - | $0.00(-100.0%) | $6.34 M(0.0%) |
| Mar 2024 | - | $1.85 M(-58.8%) | $6.34 M(+41.2%) |
| Dec 2023 | $4.50 M(-187.5%) | $4.50 M(>+9900.0%) | $4.50 M(-243.3%) |
| Sep 2023 | - | $0.00(0.0%) | -$3.14 M(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | -$3.14 M(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | -$3.14 M(-38.9%) |
| Dec 2022 | -$5.14 M(-106.3%) | -$3.14 M(<-9900.0%) | -$5.14 M(+156.9%) |
| Sep 2022 | - | $0.00(0.0%) | -$2.00 M(0.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$2.00 M(-8.1%) |
| Mar 2022 | - | -$2.00 M(<-9900.0%) | -$2.18 M(-102.7%) |
| Dec 2021 | $81.98 M(+90.4%) | $0.00(0.0%) | $81.98 M(-27.8%) |
| Sep 2021 | - | $0.00(-100.0%) | $113.59 M(0.0%) |
| Jun 2021 | - | -$176.60 K(-100.2%) | $113.59 M(-4.1%) |
| Mar 2021 | - | $82.15 M(+159.8%) | $118.41 M(+175.0%) |
| Dec 2020 | $43.05 M(+130.2%) | $31.62 M(>+9900.0%) | $43.05 M(+232.7%) |
| Sep 2020 | - | $0.00(-100.0%) | $12.94 M(+3.9%) |
| Jun 2020 | - | $4.64 M(-31.8%) | $12.46 M(-49.3%) |
| Mar 2020 | - | $6.80 M(+351.8%) | $24.56 M(+31.3%) |
| Dec 2019 | $18.71 M | $1.51 M(-412.2%) | $18.71 M(+16.2%) |
| Sep 2019 | - | -$482.20 K(-102.9%) | $16.09 M(-39.4%) |
| Jun 2019 | - | $16.74 M(+1668.4%) | $26.57 M(+124.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $946.50 K(-185.5%) | $11.83 M(-5.5%) |
| Dec 2018 | $12.52 M(+960.8%) | -$1.11 M(-111.1%) | $12.52 M(-8.1%) |
| Sep 2018 | - | $10.00 M(+399.8%) | $13.63 M(+183.7%) |
| Jun 2018 | - | $2.00 M(+22.3%) | $4.80 M(-65.4%) |
| Mar 2018 | - | $1.64 M(+39.9%) | $13.90 M(-46.4%) |
| Dec 2017 | $1.18 M(-95.2%) | - | - |
| Sep 2017 | - | $1.17 M(-89.5%) | $25.93 M(+4.7%) |
| Jun 2017 | $24.77 M(+24.5%) | $11.10 M(+1303.4%) | $24.77 M(+23.8%) |
| Mar 2017 | - | $790.70 K(-93.9%) | $20.01 M(+4.1%) |
| Dec 2016 | - | $12.88 M(>+9900.0%) | $19.22 M(-3.3%) |
| Sep 2016 | - | $2200.00(-100.0%) | $19.87 M(-0.2%) |
| Jun 2016 | $19.90 M(+59.2%) | $6.34 M(>+9900.0%) | $19.90 M(+46.7%) |
| Mar 2016 | - | $700.00(-100.0%) | $13.56 M(-18.1%) |
| Dec 2015 | - | $13.53 M(>+9900.0%) | $16.56 M(+32.1%) |
| Sep 2015 | - | $33.40 K(+2683.3%) | $12.53 M(+0.3%) |
| Jun 2015 | $12.50 M(+302.0%) | $1200.00(-100.0%) | $12.50 M(+0.0%) |
| Mar 2015 | - | $3.00 M(-68.4%) | $12.50 M(+1.1%) |
| Dec 2014 | - | $9.50 M(>+9900.0%) | $12.36 M(+310.6%) |
| Sep 2014 | - | $0.00(0.0%) | $3.01 M(-3.2%) |
| Jun 2014 | $3.11 M | $0.00(-100.0%) | $3.11 M(0.0%) |
| Mar 2014 | - | $2.86 M(+1806.7%) | $3.11 M(+1144.0%) |
| Dec 2013 | - | $150.00 K(+50.0%) | $250.00 K(+150.0%) |
| Sep 2013 | - | $100.00 K | $100.00 K |
FAQ
- What is Hepion Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual CFF year-on-year change?
- What is Hepion Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly CFF year-on-year change?
- What is Hepion Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM CFF year-on-year change?
What is Hepion Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of HEPA is $4.50 M
What is the all time high annual CFF for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual cash flow from financing activities is $81.98 M
What is Hepion Pharmaceuticals annual CFF year-on-year change?
Over the past year, HEPA annual cash flow from financing activities has changed by +$9.63 M (+187.49%)
What is Hepion Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of HEPA is $2.50 M
What is the all time high quarterly CFF for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly cash flow from financing activities is $82.15 M
What is Hepion Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, HEPA quarterly cash flow from financing activities has changed by +$2.50 M (+100.00%)
What is Hepion Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of HEPA is $8.84 M
What is the all time high TTM CFF for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM cash flow from financing activities is $118.41 M
What is Hepion Pharmaceuticals TTM CFF year-on-year change?
Over the past year, HEPA TTM cash flow from financing activities has changed by +$11.98 M (+381.90%)